TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

9.40$ -0.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCRE
Line item 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
79.8% 99.5% 100.0% 99.9%
76.0% 67.0% 96.7% 47.4%
20.1% 0.4% – –
14.5% 8.5% 5.5% 10.1%
13.7% 8.2% 5.5% 9.7%
7.0% 3.6% 2.5% 3.2%
85.5% 91.5% 94.5% 89.9%
-284.8% -256.0% -120.6% -157.6%
24.9% 23.1% 19.6% 23.1%

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?